# MS-RR-RM03
Reviewer status: R1 not reviewed, R2 not reviewed (no MS-RR notes file in this round) | Approved before this round: no

## Reviewer notes
| note id | ruling | what changed (field paths) |
| --- | --- | --- |
| (none) | n/a | No reviewer notes for this case. All changes below are own findings and the condition plan (plans/MS-RR.md). |

## Own findings
| dim | severity | field path | finding | action |
| --- | --- | --- | --- | --- |
| B | minor | `patient.neurological_exam.additional`, `.sensory` | Paresthesia dated "2 weeks ago" though the HPI places it three days after a two-week diplopia; the sensory exam "reports subjective tingling ... that has resolved" (self-contradictory). | FIXED: "began about 10 days ago, lasted approximately 2 days"; sensory exam states no residual deficit. |
| B | minor | `patient.neurological_exam.cranial_nerves`, `patient.history_present_illness` | Left-eye acuity 20/30 unexplained (keratoconus is right-sided); keratoconus "six years ago" against "diagnosed at age 22" at age 29. | FIXED: left 20/20; "seven years ago". |
| D | minor | `initial_tool_outputs.mri` | Interpretive observations ("could represent an early demyelinating plaque or a nonspecific finding", "to suggest acute ischaemia"); lesion count 8 without per-region breakdown. | FIXED: factual observations with the 8-lesion breakdown (four periventricular); pontine lesion located at the abducens fascicle in the finding; DWI stated; impression factual. No cord in the brain report (H not needed). |
| A | major | `initial_tool_outputs.csf` | Myelin basic protein; Gram stain and culture in an afebrile patient; RBC 1/uL labelled "traumatic tap"; no kFLC; recital interpretation with em dash. | FIXED: MBP, Gram stain, culture removed; RBC 1/uL; OCB 2 bands and IgG index 0.64 kept; kFLC index 14.8 (reference < 6.1) added; pattern interpretation. |
| D | minor | `initial_tool_outputs.labs` | "Mimic exclusion" HIV row with "excludes this reversible mimic"; "Fasting lipid panel — LDL"; vitamin D 18 repeated across the batch. | FIXED: HIV in a "Serology" panel, significance null; "LDL cholesterol"; vitamin D 19 ng/mL. |
| A | major | `followup_outputs` repeat MRI | 3-month repeat MRI with a new lesion (a future scan, plan F). | FIXED: deleted. |
| A | major | `followup_outputs` MG work-up | AChR/MuSK stub filed as `request_myasthenia_gravis_workup` (plan G4). | FIXED: deleted; MG is low in the differential with the reason. |
| C | major | `followup_outputs` literature | Results with unverifiable titles and no authors, empty summary (plan G7). | FIXED: Thomke 1997 JNNP, Peters 2002 Ophthalmology, Montalban 2025; general summary; optional and last. |
| C | major | `followup_outputs` drug check | Empty `interactions` with the medication check hidden in a warning; DMT alternatives argued; lymphocyte rule as a contraindication; any steroid query answered with the DMF report only. | FIXED: proposed oral methylprednisolone then dimethyl fumarate; cetirizine and cholecalciferol against both; DMF warnings (flushing, lymphopenia monitoring, baseline tests); alternatives empty. |
| B | minor | `followup_outputs[0]` spine | Side unstated; duplicate finding rows; no measurements. | FIXED: right dorsal column C5-C6 (explains the right hand tingling), 8 mm; one finding row; measurements; impression with level. |
| A | major | `ground_truth.action_criteria` | Template criteria; literature and drug required; labs nine analytes; CSF three assays together. | FIXED per plan 3.2: brain MRI, spine MRI, labs required; CSF optional (OCB or kFLC); drug and literature optional, literature last; no AQP4/MOG criterion. |
| A | minor | `ground_truth.stop_rule`, `sequence_constraints` | Literature and drug required; max 0; 2017 citation. | FIXED: required criteria only, max 2; canonical soft MRI-before-CSF. |
| C | major | `ground_truth.assessment.required_recommendations` | DIS/DIT recitals; AQP4/MOG must with no result in the case; JCV and lifestyle template lines. | FIXED: formulation (4 of 5 regions, sufficient without DIT); methylprednisolone because constant diplopia affects function; driving and occlusion advice; DMT by activity; DMF-matched pre-treatment screening; vitamin D adherence and dose. |
| C | major | `ground_truth.assessment.prohibited_recommendations` | JCV, fingolimod, teriflunomide (male patient) and myelopathy items unrelated to the case; em dashes. | FIXED: deleted; added prohibitions on attributing the diplopia to keratoconus, MG or microvascular palsy, and on requiring CSF or follow-up MRI for DIT. |
| C | major | `ground_truth.differential` | NMOSD and MOGAD "high", neurosarcoidosis "moderate" with code D86.85 (sarcoid myocarditis); Susac without any supporting feature; no MG, microvascular palsy or neuro-Behcet in a Turkish patient with a brainstem lesion. | FIXED: NMOSD, MOGAD, sarcoid (D86.89), neuro-Behcet, MG low; microvascular palsy, vasculitis, ADEM very low, features from the case; Susac removed. |
| C | minor | `ground_truth.key_clinical_evidence` | Template, engineering lines and "black holes contribute evidence of DIT" (wrong, F5). | FIXED: rebuilt from the case. |
| B | minor | `ground_truth.red_herrings` | Vitamin D value and em dash; keratoconus not marked. | FIXED: vitamin D 19; keratoconus added. |
| C | minor | `ground_truth.avoided_actions` | Template rationales and citations. | FIXED: case-tied rationales; `[Wattjes_2021]` for CT and PET. |
| E | minor | `metadata` | Condition name with em dash; difficulty text calling the CSF "borderline" and requiring CSF and AQP4/MOG. | FIXED: condition name; difficulty and revision fields. |
| A | minor | `fallback_tool_outputs.echo.echo_type` | Missing discriminator value. | FIXED: "TTE". |

## Changes, in one paragraph a physician can read before re-reviewing

A 29-year-old Turkish man with two weeks of binocular horizontal diplopia from a fixed left abduction deficit, then two days of right hand and forearm tingling that resolved; right-eye keratoconus, cetirizine and vitamin D3 taken irregularly. The brain MRI shows eight lesions (four periventricular, one left parietal juxtacortical, two subcortical, one left dorsal paramedian pontine with faint partial ring enhancement at the abducens fascicle), and the spine a right dorsal column C5-C6 lesion: DIS in 4 of 5 regions, which suffices under the 2024 criteria without DIT; CSF (two bands, kFLC 14.8) is optional support. The future repeat MRI and the myasthenia stub are gone, the literature now cites real sources. Required: brain MRI, spine MRI, mimic labs. Musts: formulation, methylprednisolone because the diplopia affects function, driving and occlusion advice, DMT by activity, screening matched to dimethyl fumarate, vitamin D. The differential now carries myasthenia, microvascular palsy and neuro-Behcet, all low, and NMOSD and MOGAD low.

## CENTRAL (requests outside this file: vocabulary, synonyms, library, tests, UI)

- Citation keys `[McDonald_2024]`, `[Wattjes_2021]`, `[NICE_NG220]` (plan 5.1); synonyms (plan 5.2).

## Open questions for Andrea (judgment calls you could not settle)

- The plan does not ask for a relapse-treatment must here. I added methylprednisolone because constant binocular diplopia affects function (NICE NG220). If you consider an isolated sixth nerve palsy mild enough to observe, change it to "offer or discuss".
- No AQP4/MOG result is stored (plan: no criterion). An agent that orders the antibodies gets no stored value; NMOSD and MOGAD are kept low on clinical and imaging grounds.

## Verification

Adversarial verifier, 24 Oct 2026. Read the whole final case. Confirmed: future repeat MRI and the MG stub deleted; no T10 (male); spine lesion right dorsal column C5-C6 explains the transient right hand tingling; DIS 4 of 5 (PV, JC, IT, cord) identical in must, KCE, criteria and metadata; CSF IgG index 0.64 within 0.28-0.66 and called normal; kFLC 14.8 added; glucose ratio 61/92 = 0.66 matches the BMP; keratoconus timeline (age 22, seven years ago at 29) and left acuity 20/20 fixed; differential carries MG, microvascular palsy and neuro-Behcet with case features; literature sources (Thomke 1997 JNNP, Peters 2002 Ophthalmology, Montalban 2025) exist as cited; drug output lists real lines.

Found and changed:
- Lesion location wording in `initial_tool_outputs.mri.findings[2].location`, `.impression`, `.additional_observations[0]`, `ground_truth.action_criteria[0].expected_evidence`, `key_clinical_evidence[1]` and `[2]`: "left dorsal paramedian pons" places the lesion at the abducens nucleus, which gives an ipsilateral horizontal gaze palsy (usually with a facial palsy), not the isolated abduction deficit in the exam. Now "left paramedian pons, in the region of the left abducens fascicle" everywhere (fascicular lesion, consistent with the isolated sixth nerve palsy and the normal face).

Open questions in this log, resolved by the verifier: (1) the methylprednisolone must stays: constant binocular diplopia that stops him driving and working affects function, which is the NICE NG220 threshold; (2) no AQP4/MOG result is stored, per plan A8 (no optic neuritis, myelitis attack or other red flag); NMOSD and MOGAD are low on imaging and CSF grounds. Note for CENTRAL: an AQP4/MOG order in this case returns the stored panel without those analytes (the lab merge does not answer analytes absent from the case); that is a library/harness behaviour, not a case edit.

perfect_agent.py -v: pass. case_io.py check: clean for this case. Guards: pass.

## Condition audit

Condition auditor, 24 Oct 2026 (uniformity scripts over all 30 MS-RR cases; edits through `case_io`; perfect agent, `case_io check` and the case guards clean afterwards).

- `ground_truth.differential[7].icd_code` G04.81 -> G04.00: G04.81 is other encephalitis; ADEM is G04.00, as in the other 8 MS-RR cases.

## Close-out (24 Oct 2026)

Condition close-out (`plans/MS-RR-decisions.md`). What changed and why:

- Diagnosis synonyms (`diagnosis_synonyms.yaml` G35 entry, re-applied with `apply_diagnosis_synonyms.py --prune --conditions multiple_sclerosis`): removed the label "demyelinating disease" (G37.9 is an Excludes1 of G35.A, and its tokens occur in an NMOSD, MOGAD or ADEM answer, which would have scored as correct) and the codes G35.B and G35.C (primary and secondary progressive MS in FY2026 ICD-10-CM, a different course from this relapsing-remitting case). Accepted now: the label, multiple sclerosis, MS, relapsing(-)remitting multiple sclerosis, RRMS; codes G35.A, G35, G35.D.
- `followup_outputs`: added the negative AQP4-IgG / MOG-IgG cell-based-assay follow-up (`interpret_labs`, trigger `request_aqp4_mog_cell_based_assay`, panel `Neuroimmunology`, after the spine MRI), as in the other 25 cases. The case has no AQP4/MOG criterion (no red flag, no optic neuritis or myelitis), so scoring is unchanged; before, an agent that ordered the assay received the first-line labs again with no antibody result (summary CENTRAL 5, open question 3). MockServer probe: all three alternatives, alone or with the mimic panel and in either order, receive the rows; the mimic panel alone does not.
- Checks: `perfect_agent.py` pass, `case_io.py check` clean for the case, `test_case_guards.py -k MS-RR-` passes with MS-RR now in `DISCRIMINATOR_CONDITIONS`.
